National drug regulator
Appears in 2 stories · Last updated Jul 28, 2026
As of July 2026: Granted trial clearance
About 700 people worldwide have a confirmed diagnosis of SYNGAP1-related disorder. It causes intellectual disability and seizures, and no drug has ever been approved to treat it. On July 27, 2026, that changed at the edges: Australia's drug regulator cleared the first medicine designed to fix the disorder's root cause to be tested in people.
Updated Jul 28
As of June 2026: Granted the approval that cleared CT:VQ for Australian sale
A patient with breathing trouble usually needs a nuclear medicine scan to see how air and blood move through the lungs. That means radioactive tracers, special cameras, and a clinic that has them. 4DMedical's CT:VQ skips all of it.
Updated Jun 29
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
